NEUARTIGE CTLA4-IG-IMMUNADHÄSINE

Patent europeic · EP3053932 · Stritgà

Inscripziun en il register

Numer da publicaziun
EP3053932
Numer da la dumonda
EP15198516
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
Stritgà
Scrittira da patent
Concedì
Annunzià
22-02-2011
Publitgà
10-08-2016
Concedì
22-07-2020
Stritgà
23-09-2026
Motiv
Taxa annuala betg pajada
Classas IPC
A61K 38/00 (2006.01)
C07K 14/705 (2006.01)
Prioritad
US 306311 P 19.02.2010
US 334806 P 14.05.2010
US 412309 P 10.11.2010
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 23-09-2026

    Stritgà, taxa betg pajada

    Status of protective title
    Active → Cancelled
    Cancellation date
    23.09.2026
    Cause for cancellation
    Non-payment of renewal fee

    Published in Swissreg on 23.09.2026

  2. 01-03-2025

    Next annual fee due on

    Next annual fee due on
    28.02.2025 → 28.02.2026

    Published in Swissreg on 01.03.2025

  3. 01-03-2024

    Midada

    Published in Swissreg on 01.03.2024

  4. 06-03-2023

    Midada

    Published in Swissreg on 06.03.2023

  5. 15-11-2020

    Represchentant inscrit

    Representative
    Novagraaf International SA, Chemin de l'Echo 3, 1213 Onex

    Published in Swissreg on 15.11.2020

  6. 22-07-2020

    Concedì

    Published in Swissreg on 22.07.2020

Partidas

Possessur

Xencor, Inc.

111 W. Lemon Avenue, Monrovia, CA 91016, US

Represchentant

Novagraaf International SA

Chemin de l'Echo 3, 1213 Onex

Inventur

BERNETT, Matthew, J.

Monrovia, CA 91016, US

LAZAR, Gregory, A.

Arcadia, CA 91007, US

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.